Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
20 participants
INTERVENTIONAL
2020-01-06
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery Outpatients
NCT03821597
Effect of Short-term Compression Therapy After Thermal Ablation for Varicose Veins
NCT05840991
Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy
NCT02890563
Efficacy of Complex Decongestive Therapy (CDT) in Patients With Venous Insufficiency: a Experimental Study
NCT06231940
Cooling Lower Leg Skin to Prevent Venous Leg Ulcers in Patients With Poor Vein Circulation
NCT01509599
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Design: This will be an investigator-initiated, evaluator-blinded, randomized-controlled, prospective, single-center clinical trial.
Study Population: 20 evaluable subjects with bilateral lower extremity reticular and telangiectatic veins, who meet all study inclusion/exclusion criteria will be considered for entry into the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment with forced-air cooling
comparing treatment with and without forced-air cooling in a comparative lower extremity model
air cooling
intervention is adding air-cooling to treatment
treatment without forced-air cooling
comparing treatment without forced-air cooling in a comparative lower extremity model
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
air cooling
intervention is adding air-cooling to treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The subject has mild venous disease (CEAP Class C1) (CLINICAL SEVERITY ETIOLOGY OR CAUSE ANATOMY AND PATHOPHYSIOLOGY)
* Reticular veins and telangiectasias on symmetrical bilateral lower extremities.
* The subject is willing to follow study instructions and complete all required visits, as well as has agreed to and signed the written informed consent form.
* The subject is healthy as judged by medical history and investigator's assessment of current health.
* The subject is not suffering from any skin condition (infection, dermatosis, etc.) that in the opinion of the investigator may place them at risk.
* Females of childbearing potential must use one of the following types of birth control for the duration of the study. These include: Oral contraceptives, contraceptive patches/rings/implants, Implanon®, Depo-Provera®, double-barrier methods (e.g. condoms with spermicide), abstinence, or partner vasectomy, with a documented second acceptable method of birth control should they become sexually active. All birth control measures must be in consistent use for at least 30 days prior to the start of study.
Exclusion Criteria
* Asymmetric amount, distribution, and/or severity of reticular veins and/or telangiectasias between lower extremities
* The subject has a CEAP Class of C2 or greater, as evidenced by clinically apparent varicosities, venous stasis, stasis dermatitis, lipodermatosclerosis, and/or venous ulceration (or history of lower leg ulcerations).
* The subject has history of or current great saphenous vein (GSV), saphenofemoral junction (SFJ), or saphenopopliteal junction (SPJ) incompetency based on prior Doppler and/or duplex evaluation or has physical exam findings suspicious for it.
* The subject has a history of deep vein thrombosis, thrombophlebitis, thromboembolic disease, and/or underlying hypercoagulable medical condition (e.g. hemophilia, Factor V deficiency).
* The subject has a history of uncontrolled or severe asthma, or asthma requiring hospitalization or intubation.
* The subject has a history of allergic reactions to sclerosing agent.
* The subject has a history of allergic reaction or sensitivity to lidocaine or epinephrine.
* Any of the following medications, procedures or treatments to the purposed treatment area/s
1. Within 6 months prior to screening visit (i.) The subject has undergone sclerotherapy
2. Within 3 months prior to screening visit (I.) NO OTHER COSMETIC OR SURGICAL TREATMENTS TO THE PURPOSED TREATMENT AREA/S
* The subject is non-ambulatory or poorly ambulatory.
* The subject has a history of neurological conditions.
* The subject is pregnant, lactating, or in child bearing age (and sexually active) and not using an approved contraceptive measure.
* The subject is taking disulfiram, tamoxifen, or oral hormone therapy (not including hormonal birth control).
* The subject has a history of noncompliance with clinical protocols.
* The subject has participated in any other clinical trial that involves an investigational medication or device within the last 30 days.
* Planning to have any treatments or procedures to bilateral lower extremities for the duration of the trial.
25 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Goldman, Butterwick, Fitzpatrick and Groff
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Dermatology Research Center/Cosmetic Laser Dermatology
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ScleroTT2019-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.